Journal List > J Korean Soc Transplant > v.25(2) > 1034358

J Korean Soc Transplant. 2011 Jun;25(2):71-75. Korean.
Published online June 30, 2011.
Copyright © 2011 The Korean Society for Transplantation
Pathogenesis of Transplant Glomerulopathy
Beom Jin Lim, M.D. and Hyeon Joo Jeong, M.D.
Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Corresponding author (Email: )
Received May 22, 2011; Accepted May 23, 2011.


Transplant glomerulopathy is a late complication of renal transplantation. The characteristic morphology of transplant glomerulopathy includes thickening of glomerular capillary loops with double contour, and duplication of glomerular basement membrane on electron microscopy. Clinical and experimental evidences support the role of antibody-mediated immune mechanism in the development of transplant glomerulopathy. Antibody-induced endothelial cell injury is the key pathogenesis of transplant glomerulopathy. The evolution of transplant glomerulopathy in the context of immunologic injury is briefly reviewed.

Keywords: Kidney glomerulus; Kidney transplantation; Graft rejection; Humoral immunity


Fig. 1
Morphologic changes of transplant glomerulopathy. Glomerular capillary loops are thickened and show double contour (A). Electron microscopy reveals the widening of lamina rara interna and newly formed lamina densa (B). The peritubular capillary basement membrane is also multilayered (C). (A; Methenamine silver stain, ×400, B; Electron microscopy, ×3,000, C; Electron microscopy, ×10,000)
Click for larger image

Fig. 2
A proposed pathogenesis of transplant glomeruopathy.
Click for larger image

1. Hamburger J, Crosnier J, Dormont J. Observations in patients with a well-tolerated homotransplanted kidney: possibility of a new secondary disease. Ann N Y Acad Sci 1964;120:558–577.
2. Fotheringham J, Angel CA, McKane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009;113:c1–c7.
discussion c7.
3. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007;7:2757–2768.
4. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991;86:464–470.
5. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993;43:1333–1338.
6. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999;10:2208–2214.
7. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001;12:574–582.
8. Regele H, Böhmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002;13:2371–2380.
9. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007;7:1743–1752.
10. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007;7:2124–2132.
11. Joosten SA, Sijpkens YW, van Ham V, Trouw LA, van der Vlag J, van den Heuvel B, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005;5:383–393.
12. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007;7:518–526.
13. Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006;6:1841–1847.
14. Smith RN, Kawai T, Boskovic S, Nadazdin O, Sachs DH, Cosimi AB, et al. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am J Transplant 2006;6:1790–1798.
15. Smith RN, Kawai T, Boskovic S, Nadazdin O, Sachs DH, Cosimi AB, et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008;8:1662–1672.
16. Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin Nephrol 2011;75:271–278.
17. Koch M, Joosten SA, Mengel M, van Kooten C, Paul LC, Nashan B. Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model. Transplantation 2005;79:753–761.
18. Cosio FG, Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant 2008;8:492–496.
19. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009;9:2312–2323.
20. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, Cameron SJ, Bao C, Fox-Talbot K, et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A 2007;104:1301–1306.
Similar articles

Legislative Issues Regarding Transplant Act

Improved Surgical Technique for Heterotopic Aortic Transplantation in Mice

The Significance and Limitation of C4d as a Biomarker in the Transplanted Kidney

Vaccination Strategy in Organ Transplantation

Treatment of Recurrent Nephrotic Syndrome after Transplantation